SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950142-11-001418
Filing Date
2011-08-08
Accepted
2011-08-08 16:29:40
Documents
1
Group Members
AISLING CAPITAL III, LPAISLING CAPITAL PARTNERS III LLCAISLING CAPITAL PARTNERS III, LPANDREW SCHIFFDENNIS PURCELLSTEVE ELMS

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D eh1100594_sc13d-pernix.htm SC 13D 240923
  Complete submission text file 0000950142-11-001418.txt   242684
Mailing Address 33219 FOREST WEST STREET MAGNOLIA TX 77354
Business Address 33219 FOREST WEST STREET MAGNOLIA TX 77354 (832) 934-1825
PERNIX THERAPEUTICS HOLDINGS, INC. (Subject) CIK: 0001024126 (see all company filings)

IRS No.: 330724736 | State of Incorp.: MD | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-50927 | Film No.: 111017505
SIC: 2834 Pharmaceutical Preparations

Mailing Address 888 Seventh Avenue, 30th Fl New York NY 10106
Business Address 888 Seventh Avenue, 30th Fl New York NY 10106 212-651-6380
AISLING CAPITAL III LP (Filed by) CIK: 0001444717 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D